Expert Highlights Importance of Molecular Testing in Patients With Lung Cancer

Fred R. Hirsch, MD, PhD, shares a message with oncologists regarding molecular testing in patients with lung cancer. He says the most important message is that molecular characterization of the patient’s tumor must be done in order to best treat the patient.

QR Code
Embed the QR code on your website:
Download
Copy